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 Food supplements, including herbal and dietary, 
constitute one of the fastest growing industries with 
expenditures reaching worldwide $60 billion annually. 
Sales of herbal dietary supplements in the United 
States increased by 7.9% in 2013, reaching a total 
estimated figure of six billion dollars (Lindstrom et al., 
2014). These sales account for approximately 20% of 
the overall drug market (Kirk and Dunker, 2014). The 
use of herbal supplements increased 20 times in the 
last 25 years, counting in 2013 with ~ 50% of the USA 
adult population as consumers (Bailey et al., 2013).  
Yet, while the appetite of consumers for supplements 
continues to increase, regulatory safety guidelines and 
the knowledge of their effects are lacking.  
 Perhaps change is in the air.  An uproar was 
raised after the investigation results of the New York 
State Attorney General’s office were reported in New 
York Times February 3, 2015 (Assoc. Press, 2015). 
Accusations that herbal supplements do not contain the 
listed ingredients prompted major retailers, including 
Walgreens, Wal-Mart, GNC, and Target, to stop 
selling several herbal supplements, including some 
store brands of ginseng (Panax trifolius), gingko 
(Gingko biloba), echinacea (Echinacea spp.) and St. 
John's wort (Hypericum perforatum).  These herbal 
supplements contained some plant compon-ents, 
including carrot powder, but no principal active 
compounds responsible for the alleged beneficial 
effects were detected. 
    
 
Our team has been investigating the molecular 
mechanisms of plant flavonoids in health using several 
model systems during the past few years.  Apigenin, a 
flavonoid abundant in celery and parsley, two 
vegetables that are quite common in the Mediterranean 
diet, is emerging as a promising anti-cancer and 
immune-regulatory molecule (Shukla and Gupta., 
2010).  Our studies have shown that apigenin and diets 
rich in apigenin induce apoptosis in cancer cells, alter 
cancer proliferative gene expression, re-duce 
inflammation and restore normal metabolic function 
(Nahomi et al., 2013).  Yet, the effects of supplements 
containing apigenin have not been studied.   
 As part of our efforts to investigate the 
mechanisms responsible for the beneficial health 
effects of dietary compounds, the content of apigenin 
was studied in several herbal supplements, using 
commonly accepted analytical assessments (Figure 1). 
In agreement with the observations of the New York 
State Attorney General’s Office, we noted several 
label discrepancies in the reported amounts and 
contents, highlighting the inconsistencies between label 
claims and supplement contents. 
In the past few years, several incidents in 
which label discrepancies have been reported, high-
lighting the need for greater government oversight. 
Dietary supplements in USA are regulated by The U.S. 
Food and Drug Administration (FDA), but under a 
different set of guidelines than those covering  
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“classical” foods and drugs.  Based on the Dietary 
Supplement Health and Education Act of 1994, 
supplement makers, unlike manufacturers for conven-
tional drugs, are exempt from demonstrating that their 
products are safe or effective.  The only require-ment 
is to report accurate and truthful labels.  If the FDA 
becomes aware of an unsafe supplement being 
marketed, they may request a warning be included on 
the label or the product be removed from the market.  
 The regulations for dietary supplements should 
be framed to ensure that consumers are protected and 
that the product is effective. The need for revised 
guidelines is becoming even more relevant considering 
that 45-50% of the USA adult population, ~16.4% of 
adolescents, and ~7 to 10.7% of children ages 5-11 
consume herbal supplements (Bailey et al., 2013).  
Racial, cultural and socio-economical differences in 
consumption have been reported. Approximately 50% 
of Native Americans and 43% of whites use 
supplements and increased use has been associated 
with higher income (Barnes et al., 2008). Supplements 
classified as non-mineral and non-vitamin are used by 
18% of adults (Barnes et al., 2008).  Fish oil (omega 
3) has been reported as the most common supplement 
consumed in the United States (Barnes et al., 2004; 
Barnes, 2008),, yet the efficacy of this supplement 
remains unknown.   
 Considered alternative medicines, herbal sup-
plements are thus commonly combined with other 
prescription medicines.  Of supplement consumers, 
72% also use prescription medications and 84% have 
consumed an over-the counter medication in the prior 
12 months (Gardiner et al., 2007).  Remarkably, a 
report published in 2007, indicates that most medical 
doctors were unaware that dietary supplements are 
subject to different FDA regulations than foods or 
prescription medicines (Ashar, et al., 2007).  Clinically 
serious interactions between prescription drugs and 
supplements have been noted in several reports 
(Kaufman et al., 2002; Ernst, 2000; Mills et al., 2004; 
Sorensen, 2002; Valli and Giardina, 2002).  Yet, any 
clinical studies that evaluate the effects of supple-
ments in combination with other drugs are, missing.  
 Surveys indicate that approximately 19% of the 
USA population have used herbs for health conditions, 
such as head or chest cold, a musculoskeletal condi-
tion, stomach or intestinal illness, anxiety/depression, 
insomnia, severe headache or migraine, menopause, 
cholesterol, and recurring pain (Barnes, et al., 2004; 
Gardiner et al., 2007; Tindle et al., 2005; Ni et al., 
2002; Fennell, 2004; Graham et al., 2005).  The 
consumer needs a better understanding and evidence 
on the benefits, and risks, associated with supple-
ments.  
The lack of quality control of herbal 
compounds at the manufacturer level is a serious 
concern in that the therapeutic effects of the com-
pounds are frequently overstated.  While central 
control features related to security and composition 
can be obtained through useful and accepted analytical 
approaches, little has been done.  Regret-tably, such 
controls are still greatly needed.  
In recent years, the availability of publications 
of scientific data has been rapidly increasing, but 
dietary studies using supplements alone or in 
combination are scarce.  To bring the true effects of 
supplements to clinical and public view, an increased 
sponsorship of clinical studies is very much needed. 
Moreover, supplemental nutrition and herbal medi-
cine should be prescribed by certified professionals 
rather than by a free and misinformed market.  Urgent 
changes are needed to:  1) to update the regulations on 
supplements and establish clear safety guidelines for 
consumers; 2) to gain a better understanding of the 
mechanisms of supplement actions and effects; and 3) 
to determine and evaluate  the possible interactions of 
supplements with drugs. 
As consumer demand for supplements 
continues to increase, limited funding for research and 
outdated safety guidelines are alarming.  More and 
better information on supplements is needed.  Yet, any 
analytical studies on supplements will apparently 
continue to be delayed due to a government, paralyzed 
by lobbyists and lack funding, continues to avoid the 
real question: as to whether   supplements are really 
safe and effective?  
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 Figure 1. Content of apigenin in different supplements.   
   Fig. 1A is apigenin standard obtained from Sigma-Aldrich, Inc.  Fig. 1C  & Fig 1D are chromatograms of two other 
         Fig. 1B is content of apignin per capsule was 9.73 mg  supplements from different manufacturers, 
  whereas label indicates 50 mg/capsule.   but expected flavonoids were not detected. 
             
 Note:  For analysis, ten supplement capsules were extracted three times with 70% methanol, filtered through a 0.2 μM  
              membrane, and 20 μL of each sample was injected into a Waters 2695 separation module with a 2996 detector  
  W2690-5 Symmetry C18 column (3.5 μm , 4.6 x 75 mm) and subsequently analyzed using Empower software  
  (Waters Corp., Milford, MA).  Concentrations were measured at 340 nm corresponding to the absorbance   
  wavelength for apigenin.  
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